Dr. Alan K Davis is an Assistant Professor of Social Work at The Ohio State University and an
Adjunct Assistant Professor in the Center for Psychedelic and Consciousness Research at
Johns Hopkins University.
• The primary objective of this talk is to show the short- and long-term results from a recent randomized clinical trial of psilocybin-assisted therapy in patients with major depressive disorder (MDD).
• The substantial negative public health impact of MDD underscores the importance of more research into drugs with rapid and sustained antidepressant effects. Existing pharmacotherapies for depression have variable efficacy and unwanted adverse effects. Novel antidepressants with rapid and sustained effects on mood and cognition could represent a breakthrough in treatment of depression and may potentially improve or save lives.
• Additional presentation components include data regarding the psychological and biological mechanisms of action, and a case report of one study volunteer highlighting the subjective effects of treatment.